18 results

  • Creon (pancrelipase)

    (Pancrelipase)
    AbbVie Inc.
    Usage: CREON® is indicated for treating exocrine pancreatic insufficiency in both adult and pediatric patients.

  • Depakote

    (Divalproex Sodium)
    AbbVie Inc.
    Usage: Depakote ER is indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. It is not effective for acute migraine treatment. Considerations regarding pregnancy and potential risks are crucial for women of childbearing potential.

  • Depakote

    (Divalproex Sodium)
    AbbVie Inc.
    Usage: Depakote (divalproex sodium) is indicated for treating manic episodes in bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Its long-term efficacy in treating mania is not established, and it should be avoided in women who are pregnant or may become pregnant.

  • Duopa

    (Carbidopa and Levodopa)
    AbbVie Inc.
    Usage: DUOPA® is indicated for treating motor fluctuations in patients with advanced Parkinson’s disease.

  • Gengraf (cyclosporine)

    (Cyclosporine)
    AbbVie Inc.
    Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.

  • Humira

    (Adalimumab)
    AbbVie Inc.
    Usage: HUMIRA is indicated for reducing signs and symptoms and improving physical function in various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and children.

  • Lupron depot

    (leuprolide acetate)
    AbbVie Inc.
    Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis, including pain relief and lesion reduction, as well as for preoperative anemia improvement in women with uterine leiomyomata (fibroids), used with iron therapy. It is not meant for prolonged use or specific combinations beyond stated limits.

  • Mavyret

    (Glecaprevir and Pibrentasvir)
    AbbVie Inc.
    Usage: MAVYRET is indicated for treating chronic hepatitis C virus (HCV) genotypes 1-6 in patients aged 3 years and older, with or without compensated cirrhosis. It is also suitable for patients with HCV genotype 1 who have previously received treatment with certain HCV inhibitors.

  • Norvir

    (Ritonavir)
    AbbVie Inc.
    Usage: NORVIR is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents in adults and pediatric patients.

  • Oriahnn

    (Elagolix and Estradiol and Norethisterone)
    AbbVie Inc.
    Usage: ORIAHNN is indicated for managing heavy menstrual bleeding associated with uterine fibroids in premenopausal women. It should be limited to 24 months of use due to the risk of potential irreversible bone loss.